NBN and melanoma: Current NCCN guidelines report an association of NBN mutations with an increased breast cancer risk (https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf), but further studies of unselected cancer patients with carefully population-matched controls are required to determine cancer risk associated with other cancer types, including melanoma.